Clinical trialObsActive not recruiting
Predicting Effective Therapy in Pancreatic Cancer
Circulating Tumor Cell and Tumor Tissue Models for Predicting Effective Pancreatic Cancer Response
- Outcome
- Ongoing
- Phase
- Obs
- Status
- Active not recruiting
- Study type
- Observational
- Start
- 24 January 2017
- Expected end
- 24 January 2027
- Enrollment
- 74 participants
- Sites
- 4
- Primary outcomes
- Progression Free Survival
- Sponsor
- Other
- Results posted
- No
- Last update
- 27 April 2026
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The purpose of this phase II study is to develop a test to predict response of pancreatic cancer to different chemotherapy regimens.